World News: 22:05 GMT Wednesday 16th May 2018. [CytomX Therapeutics Inc. via Globe Newswire via SPi World News]
SOUTH SAN FRANCISCO Calif May 16 2018 GLOBE NEWSWIRE -- CytomX Therapeutics Inc NasdaqCTMX a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probod y™ th...
Globe Newswire: 22:05 GMT Wednesday 16th May 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.